
Savings through generic drug usage in the U.S. 2008-2021
In 2021, the healthcare system in the United States saved some 373 billion U.S. dollars through the usage of generic drugs and biosimilars. Over a 10-year period (2012-2021), the U.S. saved about 2.6 trillion U.S. dollars through generic drugs and biosimilars.